
亚太地区起搏器市场至 2027 年 - 按产品类型(植入式起搏器、体外起搏器)、按技术(单腔、双腔和双心室)、最终用户(医院、门诊手术中心等)进行区域分析和预测,和国家
No. of Pages: 133 | Report Code: TIPRE00006297 | Category: Life Sciences
No. of Pages: 133 | Report Code: TIPRE00006297 | Category: Life Sciences
亚太起搏器市场预计将从 2018 年的 10.305 亿美元增至 2027 年的 22.427 亿美元。预计从 2019 年开始,该市场将以 9.2% 的复合年增长率增长 - 2027 年。
亚太地区的增长特点是老年人口、心血管疾病发病率增加、久坐的生活方式、先进技术的普及、创新和技术先进产品的不断开发以及医疗保健支出的增加
该地区日益增长的肥胖也可能引发心血管疾病。马来西亚的肥胖率在东南亚地区最高,为 14% %,其次是泰国,为 8.8%。此外,澳大利亚和新西兰的肥胖率分别为26.8%和28.3% %。此外,不健康的饮食正在导致营养过剩和肥胖。亚太地区一些国家正在观察快餐的影响。根据联合国儿童基金会2013年的报告,估计东亚太平洋地区有1100万5岁以下儿童超重。因此,这些因素导致心血管疾病的增长,并最终导致起搏器市场的增长。
此外,2016年至2019年期间,各公司在其运营的市场上制定了有机和无机增长战略。该公司开展的一些促进其发展的活动包括产品发布、收购和合作。有机发展战略的不断实施,促进了企业的成长,也带来了市场的各种变化。例如,2018年5月,中国制造商乐普医疗科技(北京)有限公司通过海外子公司乐普康(印度)血管解决方案将业务拓展至印度市场。乐普医疗科技(北京)有限公司通过子公司进入印度市场,并可能探索本地制造和合作的机会。
由于老年人口的增加以及日本主要市场参与者推出的产品等因素,预计日本在预测期内将出现增长,这可能会促进起搏器市场在预测期内的增长.
< span>
亚太起搏器市场–按
产品
类型
亚太地区起搏器市场 -按技术
亚太地区起搏器市场 -由
最终用户
按地理位置
• 亚太地区
p>
公司简介
Strategic insights for Asia Pacific Pacemakers involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2018 | US$ 1,030.5 Million |
Market Size by 2027 | US$ 2,242.7 Million |
Global CAGR (2019 - 2027) | 9.2% |
Historical Data | 2016-2017 |
Forecast period | 2019-2027 |
Segments Covered |
By 产品类型
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific Pacemakers refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies
The Asia Pacific Pacemakers Market is valued at US$ 1,030.5 Million in 2018, it is projected to reach US$ 2,242.7 Million by 2027.
As per our report Asia Pacific Pacemakers Market, the market size is valued at US$ 1,030.5 Million in 2018, projecting it to reach US$ 2,242.7 Million by 2027. This translates to a CAGR of approximately 9.2% during the forecast period.
The Asia Pacific Pacemakers Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Pacemakers Market report:
The Asia Pacific Pacemakers Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Pacemakers Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Pacemakers Market value chain can benefit from the information contained in a comprehensive market report.